Therefore, with regard to gene therapy of disease, Yaohai has the innovative and useful tool investment that red fluorescent saRNA, similar to the Yaohai's product like RNA Lyophilization Protocol. This is very cool, as it uses subtle colors to detect specific cells in the body. And it detects these cells and gives the RNA to these cells directly. The good thing it seems to do differently is an especially much better job at exploiting the treatments and having them work best where some of these older options might not.
While scientists have been studying cells in our bodies using fluorescent technology for quite some time, also the GMP CMV Antigen Manufacturing innovated by Yaohai. It allows them to see the nature of cells, how they are acting and functioning together. Red fluorescent saRNA (which works under the same premises, only that instead of hiding the beneficial RNA in NPs and sprinkling them around for it to hopefully maybe find a lock (mRNA in target cells), delivers instead an exquisitely targeted hammer seeing that right type of RNA, being one. The main difference between the red fluorescent saRNA and previous modalities is that classical gene therapy technologies can under one multiple cells at the same time while the new saRNAs are able to target only specific cells in a need of help. This will help prevent the occurrence of this side effect treatment and protect patients.
Gene therapy is the burgeoning field, similar to the Yaohai's product like E. coli Fermentation for VLP Production. Then daily it is creating even more new techniques and tools so that there is a way, for us to showcase better behavior against diseases. One such new tool is the Red Fluorescent saRNA. This will enable the researchers to track where in the body helpful RNA goes and how it could support a cell that lacks it. This is a good trait because it allows doctors to more usefully direct treatments at cut diseases, like cancer.
In addition to the desirable properties of a red fluorescent saRNA, this work can provide yet another piece of information about how RNA novelty uses in our bodies, also the mRNA Plasmid Manufacturing built by Yaohai. With these colorful tints, scientists can pass the RNA to some cells and see how that may help in treatment. It might yield novel approaches for treating a broad spectrum of diseases. For example, this type of AI could shed a light on the RNA-Cell interactions which then lead to personalised medications.
Red fluorescent saRNA is still being tested in the laboratory, but previous results on animal models are very good, similar to the Yaohai's product like Red Fluorescent mRNA. Scientists all over the world are researching in depth to use this technology in healthcare and moving towards new aspects including drug delivery. But as this technology improves, I suspect we will use AI broadly in health care over time. This may be tracking and treating diseases down to a pinpoint, but could also mean creating new vaccines to prevent diseases.
Yaohai Bio-Pharma, a top 10 producer of biological products, is a specialist in microbial fermentation. We have established an advanced facility that is equipped with modern facilities and strong RD manufacturing capabilities. We have five drug substance manufacturing lines that are in compliance with GMP requirements for microbial fermentation and purification, as well as two fill-finish lines that are automated for cartridges, vials, as well as pre-filled syringes. The available fermentation scales vary from 100L to 500L, 1000L and 2000L. Red Fluorescent saRNA for vias are 1ml to 25ml, whereas the pre-filled syringes and cartridge filling specifications cover 1-3ml. Our production workshop is cGMP compliant and guarantees steady supply of clinical samples as well as commercial items. Our plant produces large molecules which are shipped to the globe.
Yaohai Bio-Pharma is a leading Microbial biologics CDMO. We have been focused on microbial-produced therapeutics and vaccines for human, veterinary, and the management of pet health. We are equipped with Red Fluorescent saRNA RD platforms as well as manufacturing technology that encompass the entire process beginning with the development of microbial strains cells, methods and processes, to commercial and clinical manufacturing which ensures successful implementation of cutting-edge solutions. We have acquired a large amount of experience in bio processing of microbial cells. We have delivered over 200 global projects, and help our clients with navigating the laws from the US FDA, EU EMA, Australia TGA, and China NMPA. Our professional expertise and extensive experience allows us to quickly respond to market demands and provide tailored CDMO services.
Yaohai Bio-Pharma has experience in the manufacture of biologics created from microorganisms We offer bespoke RD solutions as well as manufacturing services while minimizing the risk We've worked with diverse modalities such as recombinant subunit vaccines peptides hormones cytokines growth factors mono-domain antibodies enzymes plasmid DNA the mRNA and other We've specialized in several microorganisms like yeast extracellular and intracellular secretion (yields up to 15g/L) bacteria intracellular soluble and inclusion bodies (yields up to 10g/L) We have also created a BSL-2 fermentation system to create Red Fluorescent saRNA vaccines We are experts in optimizing production processes increasing yields and decreasing costs We have a highly efficient technology team that ensures timely and top-quality project delivery This allows us to deliver your products that are unique faster to the market
Yaohai BioPharma, a top 10 Red Fluorescent saRNA, combines regulatory affairs and quality control. We have a quality system that is compliant with current GMP standards and regulations around the globe. Our regulatory team has deep understanding of world-wide regulatory frameworks. This lets us accelerate biological launches. We ensure traceable production procedures with high-quality products as well as compliance with the regulations of the US FDA and EU EMA. Australia TGA and China NMPA is also fulfilled. Yaohai BioPharma successfully passed an in-person audit conducted by an accredited Qualified Person of the European Union (QP) to examine our GMP system and production facility. We have also passed the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.